Patent details

Basic Information

Publication number:

EP3177325

PCT Application Number:

EP2015068203

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157660549

PCT Publication Number:

WO2016020499

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED HOST CELLS AND HYBRID OLIGOSACCHARIDES FOR USE IN BIOCONJUGATE PRODUCTION

French Title of Invention:

CELLULES HÔTES MODIFIÉES ET OLIGOSACCHARIDES HYDRIDES UTILISABLES DANS LA PRODUCTION DE BIOCONJUGUÉS

German Title of Invention:

MODIFIZIERTE WIRTSZELLEN UND OLIGOSACCHARID-HYBRIDE ZUR VERWENDUNG IN DER HERSTELLUNG VON BIOKONJUGATEN

SPC Number:

Dates

Filing date:

06/08/2015

Grant date:

01/04/2020

EP Publication Date:

14/06/2017

PCT Publication Date:

11/02/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/04/2020

EP B1 Publication Date:

01/04/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/08/2020

Expiration date:

06/08/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/03/2020

 

 

Name:

GlaxoSmithKline Biologicals S.A.

Address:

Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Inventor

Name:

FARIDMOAYER, Amirreza

Address:

Switzerland (CH)

Priority

Priority Number:

201462035360 P

Priority Date:

08/08/2014

Priority Country:

United States (US)

Classification

IPC classification:

C07K 14/195; C12N 1/21; C12N 9/10; C12P 19/28; A61K 47/50;

Publication

European Patent Bulletin

Issue number:

202014

Publication date:

01/04/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages